A double-blind controlled evaluation of Actifed and its individual constituents in allergic rhinitis.

Connell, J T; Williams, B O; Allen, S; Cato, A; Perkins, J G

Connell, J T; Williams, B O; Allen, S; Cato, A; Perkins, J G.

J Int Med Res ; 10(5): 341-7, 1982.

Article in En | MEDLINE | ID: mdl-6128282

ABSTRACT

ABSTRACT

Pseudoephedrine and triprolidine, administered every 6 hours as a combination, made separate and distinct contributions to the treatment of allergic rhinitis. Furthermore, the combination was perceived by the patients as being clinically superior to either of its components or placebo.

Subject(s)

Ephedrine/therapeutic use; Histamine H1 Antagonists/therapeutic use; Pyridines/therapeutic use; Rhinitis, Allergic, Seasonal/drug therapy; Triprolidine/therapeutic use; Clinical Trials as Topic; Double-Blind Method; Drug Combinations/therapeutic use; Humans; Placebos; Pseudoephedrine

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Triprolidine / Rhinitis, Allergic, Seasonal / Ephedrine / Histamine H1 Antagonists Type of study: Clinical_trials Limits: Humans Language: En Journal: J Int Med Res Year: 1982 Type: Article

Search on Google

XML

PubMed Links